Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction

Journal of Thrombosis and Thrombolysis

Volumn 26, Issue 3, 2008, Pages 196-202

  Brunetti, Natale Daniele ^a   Pellegrino, Pier Luigi ^a   Correale, Michele ^a   De Gennaro, Luisa ^a   Cuculo, Andrea ^a   Di Biase, Matteo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Acute heart failure; Acute phase proteins; ST elevation myocardial infarction

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; ALPHA1 GLYCOPROTEIN; C REACTIVE PROTEIN; CERULOPLASMIN; HAPTOGLOBIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; ST SEGMENT ELEVATION; SYSTOLIC DYSFUNCTION;

ACUTE-PHASE PROTEINS; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 56349140814     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0088-7     Document Type: Article

References (39)

1. Lind L (2003) Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169(2):203-214
2. Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB (2002) For the intermountain heart collaborative (IHC) study group. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 89:145-149
3. Brunetti ND, Troccoli R, Correale M, Pellegrino PL, Di Biase M (2006) C-reactive protein in patients with acute coronary syndrome: Correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol 109:248-256 (available online 1 August 2005)
4. Brunetti ND, Correale M, Pellegrino PL, Cuculo A, Di Biase M (2007) Acute phase proteins in patients with acute coronary syndrome: correlations with diagnosis, clinical features and angiographic findings. Eur J Intern Med 18:109-117
5. Gabriel AS, Martinsson A, Wretlind B, Ahnve S (2004) IL-6 levels in acute and post myocardial infarction: Their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure. Eur J Intern Med 15(8):523-528
6. Toutouzas K, Stougiannos P, Drakopoulou M, Mitropoulos J, Bosinakou E, Markou V, Latsios G, Karabelas I, Stefanadi E, Stefanadis C (2007) Coronary sinus thermography in idiopathic dilated cardiomyopathy: correlation with systemic inflammation and left ventricular contractility. Eur J Heart Fail 9:168-172 (Epub 2006 May 30)
7. Shah SJ, Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, Huddleston M, Foster E, Chatterjee K, Michaels AD (2006) High-sensitivity C-reactive protein and parameters of left ventricular dysfunction. J Card Fail 12:61-65
8. Joint European Society of Cardiology/American College of Cardiology Committee (2000) Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21:1502-1513
9. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K, ESC Committe for Practice Guideline (CPG) (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The task force on acute heart failure of the European society of cardiology. Eur Heart J 26(4):384-416 (Epub 2005 Jan 28)
10. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E (2002) Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105:1760-1763
11. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D'Agostino RB (2003) Framingham Heart Study. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: The Framingham Heart Study. Circulation 107:1486-1491
12. Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, Levy Y, Beyar R, Markiewicz W, Hammerman H, Aronson D (2006) Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 47:962-968
13. Berton G, Cordiano R, Palmieri R, Pianca S, Pagliara V, Palatini P (2003) C-reactive protein in acute myocardial infarction: Association with heart failure. Am Heart J 145:1094-1101
14. Ishikawa C, Tsutamoto T, Fujii M, Sakai H, Tanaka T, Horie M (2006) Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy. Circ J 70:857-863
15. Mueller C, Laule-Kilian K, Christ A, Brunner-La Rocca HP, Perruchoud AP (2006) Inflammation and long-term mortality in acute congestive heart failure. Am Heart J 151:845-850
16. Marcucci R, Gori AM, Giannotti F, Baldi M, Verdiani V, Del Pace S, Nozzoli C, Abbate R (2006) Markers of hypercoagulability and inflammation predict mortality in patients with heart failure. J Thromb Haemost 4:1017-1022
17. White M, Ducharme A, Ibrahim R, Whittom L, Lavoie J, Guertin MC, Racine N, He Y, Yao G, Rouleau JL, Schiffrin EL, Touyz RM (2006) Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: Improvement after short-term inotropic support. Clin Sci 110:483-489
18. Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, Signorini S, Mocarelli P, Hester A, Glazer R, Cohn JN, Val-HeFT Investigators (2005) C-reactive protein in heart failure: Prognostic value and the effect of valsartan. Circulation 112:1428-1434. (Epub 2005 Aug 29)
19. Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, Gonzalez-Arencibia C (2002) C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail 4:331-336
20. Kazmierczak E, Sobieska M, Kazmierczak M, Mrozikiewicz A, Wiktorowicz K (1999) Intense acute phase response in ischemic patients. Int J Cardiol 68:69-73
21. Lind P, Hedblad B, Stavenow L, Janzan L, Eriksson KF, Lindgarde F (2001) Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: A long-term cohort study. Arterioscler Thromb Vasc Biol 21:452-458
22. Engström G, Hedblad B, Stavenow L, Tyden P, Lind P, Janzan L, Lindgarde F (2004) Fatality of future coronary events is related to inflammation-sensitive plasma proteins a population-based prospective cohort study. Circulation 110:27-31
23. Engström G, Lind P, Hedblad B, Stavenow L, Janzan L, Lindgarde F (2002) Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 105:2632-2637
24. Engström G, Lind P, Hedblad B, Stavenow L, Janzan L, Lindgarde F (2002) Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke 33:2744-2749
25. Engström G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzan L, Lindgarde F (2003) Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: A population-based study. Diabetes 52:442-447
26. Engström G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzan L, Lindgarde F (2002) Lung function and cardiovascular risk: Relationship with inflammation-sensitive plasma proteins. Circulation 106:2555-2660
27. Henry OF, Blacher J, Verdavaine J, Duviquet M, Safar ME (2003) Alpha 1-acid glycoprotein is an independent predictor of in-hospital death in the elderly. Age Ageing 32:37-42
28. Christiansen MS, Hommel E, Magid E, Feldt-Rasmussen B (2002) Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with Type II diabetes. Diabetologia 45:115-120
29. Kazmierczak M, Sobieska M, Wiktorowicz K, Wysocki H (1995) Changes of acute phase proteins glycosylation profile as a possible prognostic marker in myocardial infarction. Int J Cardiol 49:201-207
30. Suleiman M, Aronson D, Asleh R, Kapeliovich MR, Roguin A, Meisel SR, Shochat M, Sulieman A, Reisner SA, Markiewicz W, Hammerman H, Lotan R, Levy NS, Levy AP (2005) Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. Diabetes 54:2802-2806
31. Elsherif L, Ortines RV, Saari JT, Kang YJ (2003) Congestive heart failure in copper-deficient mice. Exp Biol Med 228:811-817
32. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S (1998) Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation 98:149-156
33. Ueland T, Aukrust P, Yndestad A, Otterdal K, Froland SS, Dickstein K, Kjekshus J, Gullestad L, Damas JK (2005) Soluble CD40 ligand in acute and chronic heart failure. Eur Heart J 26:1101-1107 (Epub 2005 Feb 16)
34. Kotlyar E, Vita JA, Winter MR, Awtry EH, Siwik DA, Keaney JF Jr, Sawyer DB, Cupples LA, Colucci WS, Sam F (2006) The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure. J Card Fail 12:122-127
35. Kalra D, Sivasubramanian N, Mann DL (2002) Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway. Circulation 105:2198-2205
36. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81:627-635
37. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97:1382-1391
38. Kubota T, Bounoutas GS, Miyagishima M, Kadokami T, Sanders VJ, Bruton C, Robbins PD, McTiernan CF, Feldman AM (2000) Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 101:2518-2525
39. Windram JD, Loh PH, Rigby AS, Hanning I, Clark AL, Cleland JGF (2007) Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. Am Heart J 153:1048-1055